 |
Corporate News
05-Jun-24
|
|
|
|
|
|
|
|
|
|
|
|
Lupin acquires Sanofi brands - Aarane™ and Nalcrom™
|
|
|
|
|
|
|
|
Lupin today announced that its European hub entity, Lupin Atlantis Holdings SA, has completed the acquisition of two well-known
brands, Aarane™ in Germany and Nalcrom™ in Canada and the Netherlands, along with the associated trademark rights, from Sanofi.
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas, where the company has a leading position, with high-quality products that are innovative or unique in the market.
This acquisition will enhance Lupin's Respiratory business in Germany, by aiding in the expansion of the newly established franchise, following the introduction of Luforbec™.
|
|
|
|
Previous News |
Lupin fixes record date for dividend
(
Market Beat
-
Reports
04-Jul-24
15:27
)
|
|
|
Market hits fresh life highs; Nifty ends above 24,000 level
(
Market Commentary
-
The Week That Was
28-Jun-24
16:33
)
|
|
|
Lupin to pay fine of Euro 40 million to European Commission
(
Corporate News
-
28-Jun-24
09:08
)
|
|
|
Lupin gains on receiving EIR from USFDA for New Jersey facility
(
Hot Pursuit
-
24-Jun-24
10:32
)
|
|
|
Lupin allots 43,475 equity shares under ESOP
(
Corporate News
-
21-Jun-24
12:12
)
|
|
|
Lupin Ltd slips for fifth straight session
(
Hot Pursuit
-
18-Jun-24
13:35
)
|
|
|
Lupin appoints Abdelaziz Toumi as CEO of API CDMO arm
(
Hot Pursuit
-
17-Jun-24
12:28
)
|
|
|
Lupin appoints Abdelaziz Toumi as CEO of Lupin Manufacturing Solutions
(
Corporate News
-
17-Jun-24
12:05
)
|
|
|
Lupin Nagpur unit clears USFDA inspection
(
Hot Pursuit
-
14-Jun-24
11:24
)
|
|
|
Lupin's Nagpur facility successfully clears USFDA audit
(
Corporate News
-
14-Jun-24
10:25
)
|
|
|
Lupin to transfer its trade generics biz in India to Lupin Life Sciences
(
Corporate News
-
08-Jun-24
14:09
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|